🌙 Puberty & the Menstrual Cycle
Puberty Sequence
- Menarche typically follows thelarche by roughly 2 years; average onset 11–14 years.
- Male puberty runs later on average (~two years behind girls, often noted around age 15) and is driven by rising testosterone: testicular/genital growth, increased hair distribution, deepening of the voice, nocturnal emissions, and a lean-to-muscular growth spurt.
- Precocious puberty = secondary sexual characteristics before age 8 (girls) or 9 (boys).
- Central (GnRH-dependent): premature activation of the hypothalamic pulse generator — FSH/LH rise appropriately and drive gonadal steroid production. Most central cases are idiopathic/familial early activation of an otherwise normal axis rather than a sign of underlying pathology, though it still warrants evaluation given the psychosocial impact of early development.
- Peripheral (GnRH-independent): gonadotropin-independent excess sex steroid from a gonadal/adrenal tumor or exogenous source; FSH/LH are suppressed.
- Incomplete/partial precocious puberty: an isolated pubertal feature appears early without the full cascade — premature thelarche (isolated early breast budding), premature adrenarche (isolated early axillary hair), premature pubarche (isolated early pubic hair). These are generally benign and self-limited, not a sign of a central or peripheral process, but should be distinguished from true precocious puberty on exam.
- Delayed puberty = no secondary sexual characteristics by age 13 (girls) or 14 (boys). Two broad buckets: hypergonadotropic (1°) causes where the gonad itself has failed (Turner syndrome, Klinefelter syndrome, chemotherapy/radiation injury) vs. hypogonadotropic (2°) causes where the central drive is missing (constitutional delay — the most common cause, essentially "late blooming" with a family history of the same; Kallmann syndrome; CNS lesions).
| Sexual maturity (Tanner) stage | Typical age | What's happening |
|---|---|---|
| I | Pre-pubertal | No pubic/axillary hair; prepubertal breast/genital contour |
| II | ~8–11.5y (girls) / ~9–12y (boys) | First visible pubic hair (pubarche); breast budding (thelarche) in girls, testicular enlargement in boys — usually the earliest visible sign of puberty in each sex |
| III | ~11.5–13y | Pubic hair coarsens; breast tissue and areola enlarge together; penile length increases |
| IV | ~13–15y | Adult-textured pubic hair sparing the thighs; breast areola forms a secondary mound; penile width/glans development |
| V | Usually >15y | Adult pattern and proportions throughout |
Genitalia, pubic hair, and breast development are each staged independently — a given patient can be at different Tanner stages for different features simultaneously.
Central and peripheral precocious puberty are distinguished by whether gonadotropins are appropriately elevated (central — real activation of the HPO axis) or suppressed (peripheral — an autonomous steroid source bypassing the axis entirely) — the same logic used everywhere else on this page to localize a hormonal disorder.
The HPO Axis, Step by Step
Mittelschmerz ("middle pain") is unilateral, mid-cycle pelvic pain from the follicular rupture itself and the peritoneal irritation from the small amount of bleeding it causes — usually mild, but can mimic appendicitis closely enough to confuse the picture.
Follicular vs. Luteal Phase
Follicular / Proliferative (variable length)
- Dominant follicle selected; others undergo atresia.
- Rising estrogen → endometrial proliferation, thinned/watery cervical mucus (favors sperm transit).
- Ends abruptly with the LH surge → ovulation (~day 14 in a 28-day cycle).
Luteal / Secretory (fixed ~14 days)
- Corpus luteum dominates; progesterone converts endometrium to a secretory, glandular state ready for implantation.
- Progesterone raises basal body temperature ~0.5°C — used clinically/for fertility tracking as an ovulation marker.
- Without fertilization/hCG rescue, the corpus luteum regresses → progesterone falls → menses.
Hormone Functions to Memorize Cold
| Hormone | Key actions |
|---|---|
| Estrogen | Endometrial proliferation, thin/watery cervical mucus, breast duct growth, bone formation (favors osteoblasts), induces its own receptor and the progesterone receptor |
| Progesterone | Secretory endometrial transformation, thick/tacky cervical mucus (hostile to sperm), relaxes myometrium, raises basal body temperature, breast lobular/glandular development |
| LH | Triggers ovulation; drives theca-cell androgen synthesis; sustains the early corpus luteum |
| FSH | Recruits/matures the follicle cohort; drives granulosa aromatase activity |
Estrogen and progesterone act as a functional pair on the same tissues, in opposite directions: estrogen proliferates the endometrium and thins cervical mucus to favor sperm transit, while progesterone secretes/matures the endometrium and thickens mucus to favor implantation and block further sperm entry.
The Follicle's Histologic Life Cycle
- Each cycle, a cohort of follicles is recruited but only one normally reaches dominance — the rest undergo atresia (programmed regression), which is the fate of the overwhelming majority of a woman's lifetime follicle pool.
- After ovulation, the ruptured follicle's remaining granulosa/theca cells luteinize to form the corpus luteum, which secretes progesterone.
- Without hCG rescue, the corpus luteum degenerates into the corpus albicans — an inactive, fibrotic scar — as progesterone withdraws and menses begins.
🤰 Pregnancy, Placenta & Complications
The early hormonal handoff below only makes sense against the normal cycle it's rescuing — hCG's job is specifically to prevent the corpus luteum from regressing the way it normally would post-ovulation, a process explained in Menstrual Cycle & Hormonal Axis → The Follicle's Histologic Life Cycle.
Hormonal Handoff Across Gestation
Pregnancy Terminology & a Second Placental Hormone
- Fertilization happens in the ampulla of the fallopian tube, typically within a day of ovulation; implantation follows about 6 days later.
- Embryonic (developmental) age is measured from fertilization and is the convention used in embryology. Gestational age — the one used clinically — is measured from the first day of the last menstrual period, roughly two weeks earlier, since it doesn't require knowing the exact fertilization date.
- Gravidity is the total number of pregnancies a person has had; parity is the number of those pregnancies that reached ≥20 weeks of gestation — a multiple gestation (e.g., twins) still only counts as one pregnancy toward both.
- Human placental lactogen (hPL), also called chorionic somatomammotropin, is a growth-hormone/prolactin-like hormone from the syncytiotrophoblast that rises steadily across gestation (tracking placental mass, so it's higher in multiple gestations). It increases maternal lipolysis and insulin resistance, which shifts more glucose and free fatty acids toward the fetus — helpful in a normal pregnancy, but the same mechanism is what tips a mother with limited pancreatic reserve into gestational diabetes. It also supports breast development alongside estrogen and progesterone.
Lactation — Why Milk Doesn't Come In Until After Delivery
- Prolactin rises progressively across gestation and is the hormone that actually drives milk production, but the high estrogen and progesterone of pregnancy directly block prolactin's action on breast tissue — this is what keeps lactation suppressed until delivery.
- Once the placenta is delivered, estrogen and progesterone fall sharply, unblocking prolactin's effect → milk production begins.
- Prolactin also suppresses GnRH pulsatility, which is why exclusive, frequent breastfeeding delays return of ovulation postpartum (though it is not a fully reliable contraceptive method on its own).
Abnormal Placentation
| Condition | Defect | Classic presentation |
|---|---|---|
| Placenta previa | Placenta implants over/near the internal cervical os | Painless third-trimester bleeding |
| Placental abruption | Premature separation of a normally implanted placenta from the uterine wall | Painful bleeding, tender rigid uterus, high risk of fetal compromise and maternal DIC |
| Placenta accreta spectrum | Abnormally deep attachment into (accreta), through (increta), or beyond (percreta) the myometrium due to defective decidua, usually from prior uterine surgery | Massive hemorrhage at attempted delivery/separation |
| Vasa previa | Fetal (not maternal) vessels run unprotected over or near the internal cervical os — classically from a cord that inserts into the membranes rather than the placenta itself | Painless bleeding at membrane rupture, with fetal heart rate abnormalities — the bleeding is fetal blood, so it can cause fetal exsanguination quickly even though it looks like a small bleed |
Memory anchor: previa = "in the way" (painless); abruption = "torn away" (painful).
Ectopic Pregnancy
- Implantation outside the uterine cavity, overwhelmingly in the fallopian tube.
- Risk factors share a common theme of prior tubal damage: pelvic inflammatory disease/salpingitis, prior tubal surgery, prior ectopic, endometriosis.
- Classic triad: amenorrhea, unilateral pelvic pain, vaginal bleeding — with β-hCG that rises more slowly than expected for gestational age and no intrauterine pregnancy on ultrasound once hCG crosses the discriminatory threshold.
- Tubal rupture is a surgical emergency (hemoperitoneum).
Hypertensive Disorders of Pregnancy
- Magnesium sulfate is used for seizure prophylaxis/treatment, not as definitive therapy.
- The only definitive cure for preeclampsia/eclampsia is delivery of the placenta.
Gestational HTN, preeclampsia, and eclampsia are a severity spectrum of the same abnormal placentation process, not three separate diseases — proteinuria/end-organ dysfunction marks the step from gestational HTN to preeclampsia, and seizures mark the step to eclampsia.
Gestational Trophoblastic Disease
| Type | Karyotype/origin | Features |
|---|---|---|
| Complete mole | 46,XX (or XY), entirely paternal (empty egg fertilized by one sperm that duplicates) | No fetal tissue; markedly elevated β-hCG; "snowstorm"/"cluster of grapes" ultrasound pattern; p57 stain is negative (this protein is only expressed from the maternal allele, and the complete mole has none); ~15–20% risk of progressing to an invasive mole and ~2% risk of choriocarcinoma |
| Partial mole | Triploid (69,XXY typical) — one egg fertilized by two sperm | Some fetal/embryonic tissue present; lower hCG elevation; p57 stain is positive (a maternal allele is present); lower malignant potential |
Both mole types can produce hCG-driven downstream effects: hyperthyroidism (hCG weakly cross-stimulates the TSH receptor), theca lutein cysts, hyperemesis gravidarum, and preeclampsia unusually early (before 20 weeks) — an early-preeclampsia presentation should always prompt consideration of a molar pregnancy.
p57 positivity tracks the presence of a maternal allele — negative in a complete mole (purely paternal DNA, no maternal contribution) and positive in a partial mole (triploid, with a maternal allele present) — which is why p57 staining, not hCG level alone, is what definitively distinguishes the two on pathology.
Choriocarcinoma
- A rare, aggressive malignancy of trophoblastic tissue (both cytotrophoblast and syncytiotrophoblast elements) that, unlike a mole, contains no chorionic villi.
- Most often follows an abnormal pregnancy — a molar pregnancy or a miscarriage — but can also arise nongestationally as a germ cell tumor in the ovary or testis (see the oncology sections below).
- Presents with abnormal uterine bleeding and the same hCG-driven effects as a mole, plus dyspnea/hemoptysis from early hematogenous spread to the lungs ("cannonball" metastases on chest imaging).
- Treated with methotrexate, to which it's highly sensitive.
Gestational Diabetes
- Placental hormones (human placental lactogen, cortisol, progesterone) are physiologically diabetogenic — they antagonize insulin to spare glucose for the fetus; gestational diabetes occurs when maternal insulin secretion cannot compensate.
- Screened via glucose challenge in the second trimester, confirmed with a formal oral glucose tolerance test.
- Fetal risk: hyperglycemia crosses the placenta → fetal hyperinsulinemia → macrosomia, birth trauma, and rebound neonatal hypoglycemia after cord clamping removes the maternal glucose supply.
Congenital (TORCH) Infections
- A shared group of organisms that cross the placenta (or infect intrapartum) and cause fetal anomalies, most severe with first-trimester exposure: Toxoplasma gondii, other agents (syphilis, varicella, parvovirus B19, HIV, hepatitis B), Rubella, Cytomegalovirus, Herpes simplex virus.
- Herpes simplex is the outlier — transmission is typically intrapartum (through an infected birth canal) rather than transplacental, which is why active genital lesions at term prompt cesarean delivery.
Prenatal Screening & Diagnostic Testing — Full Timeline
Worth separating two categories: screening tests estimate risk from maternal blood/imaging without fetal sampling (safe, non-diagnostic), while diagnostic tests sample fetal/placental tissue directly (small procedural risk, but definitive).
| Test | Timing | Type | What it detects |
|---|---|---|---|
| First-trimester combined screen (nuchal translucency + PAPP-A + free β-hCG) | ~10–13 weeks | Screening | Risk estimate for trisomy 21/18; increased nuchal translucency also raises suspicion for major cardiac defects |
| Cell-free fetal DNA (NIPT) | ≥10 weeks | Screening (highly sensitive, still not diagnostic) | Analyzes placental-derived cfDNA in maternal blood for common trisomies and fetal sex; a positive result still requires diagnostic confirmation |
| Chorionic villus sampling | ~10–13 weeks | Diagnostic | Karyotype/genetic analysis from placental tissue; earlier than amniocentesis but no amniotic fluid means no AFP data (cannot assess neural tube defects) |
| Quad screen (AFP, hCG, estriol, inhibin A) | ~15–20 weeks | Screening | Down syndrome pattern: ↓AFP, ↑hCG, ↓estriol, ↑inhibin A. Edwards syndrome (trisomy 18) pattern: all four analytes low. Isolated ↑AFP suggests a neural tube or abdominal wall defect rather than aneuploidy |
| Amniocentesis | ≥15 weeks | Diagnostic | Karyotype, AFP, infection studies, fetal lung maturity assessment later in gestation |
| Obstetric (anatomy) ultrasound | Throughout pregnancy, with the dedicated survey ~18–20 weeks | Screening/imaging | Fetal sizing/dating, fetal sex, and detection of structural malformations — the primary imaging tool of prenatal care, complementing rather than replacing genetic testing |
Apgar Score — Newborn Transition Assessment
- Scored at 1 and 5 minutes after birth (repeated later if persistently low); each of five categories is scored 0, 1, or 2, for a maximum of 10.
- Categories: skin color, heart rate, reflex irritability, muscle tone, and respiratory effort.
- Purpose is to flag a newborn needing resuscitation/closer monitoring, not to predict long-term neurologic outcome — a low 1-minute score that improves by 5 minutes is reassuring.
Peripartum Emergencies
| Condition | Key points |
|---|---|
| Postpartum hemorrhage | Greater-than-expected blood loss after delivery — the leading cause of maternal mortality worldwide. Four causes worth having as a checklist: uterine atony (a soft, "boggy," poorly contracted uterus — by far the most common), trauma (lacerations, uterine rupture), retained tissue (placental fragments left behind), and coagulopathy. First-line treatment is uterine massage plus oxytocin; refractory bleeding may require surgical ligation of the uterine or internal iliac arteries — fertility can still be preserved afterward because the ovarian arteries provide collateral flow. |
| Uterine rupture | Full-thickness tear through the uterine wall, most often during labor in a patient with a prior C-section scar. Presents with painful vaginal bleeding, fetal heart rate abnormalities, easily palpable fetal parts through the abdomen, and loss of the fetal station that had already been achieved — an obstetric emergency for both mother and fetus. |
| Supine hypotensive syndrome | After ~20 weeks, lying flat lets the gravid uterus compress the aorta and IVC, reducing both placental perfusion and maternal venous return. Simply repositioning the patient onto her left side relieves the compression and restores flow. |
Each peripartum emergency here fails at a different point: atony is a uterus that won't contract, rupture is a uterine wall that gives way, and supine hypotensive syndrome is external vascular compression — same clinical window, three unrelated mechanisms worth keeping separate.
Neonatal Birth Weight
| Low birth weight (<2500 g) | Macrosomia (>4000 g) | |
|---|---|---|
| Typical drivers | Prematurity, fetal growth restriction | Constitutional/genetic factors; maternal obesity or diabetes |
| Main risk | Higher mortality (including SIDS) and morbidity | Birth trauma, including shoulder dystocia |
💊 Contraception
Estrogen suppressing FSH and progestin blocking the LH surge only make sense as contraceptive levers because of the two-cell, two-gonadotropin dependency of follicle selection and ovulation laid out in Menstrual Cycle & Hormonal Axis → The HPO Axis, Step by Step.
Combined Hormonal Contraceptives
- Estrogen component: suppresses FSH → prevents dominant follicle selection.
- Progestin component: suppresses the LH surge (blocks ovulation), thickens cervical mucus, and thins the endometrium.
- Non-contraceptive benefits: lighter/more predictable menses, reduced risk of ovarian and endometrial cancer, improved acne/hirsutism (antiandrogenic progestins).
- Major risk: venous thromboembolism, amplified by smoking plus age >35 — this combination is an absolute contraindication.
- Also avoid in migraine with aura, uncontrolled hypertension, and known thrombophilia.
- Less commonly tested but real adverse effects: benign hepatic adenomas (rare but classically linked to long-term combined OCP use) and increased risk of cholesterol gallstone formation from estrogen's effect on bile cholesterol saturation.
Progestin-Only Methods
- Mechanism relies primarily on cervical mucus thickening and endometrial thinning rather than reliable ovulation suppression (with oral progestin-only pills).
- Preferred over estrogen-containing options in breastfeeding, smokers >35, or a history of thrombosis.
- Long-acting reversible options (implants, injections, hormonal IUD) have the lowest failure rates of any reversible method — failure rates are driven by consistency of use, and these remove the user-error variable.
Emergency & Termination Agents
- Levonorgestrel (emergency contraception): works primarily by delaying/blocking ovulation — ineffective once ovulation has already occurred.
- Mifepristone: competitive progesterone-receptor antagonist → withdraws progesterone support from the endometrium/decidua, used for medical termination, typically paired with a prostaglandin (misoprostol) to promote expulsion.
Levonorgestrel only works before ovulation, since it can't reverse an LH surge already underway — that timing gap is exactly what ulipristal's partial progesterone-receptor antagonism was designed to close, giving it a longer effective window than levonorgestrel.
🎗️ Gynecologic Neoplasms
The HPV → CIN → invasive carcinoma progression here is driven by the E6/E7 oncoprotein inactivation of p53/Rb described for high-risk HPV strains in Sexually Transmitted Infections → Cervicitis / PID Organisms & Other Common STIs.
Ovarian Tumors — Organize by Cell of Origin
- Risk rises with the total number of lifetime ovulations — early menarche, late menopause, nulliparity all increase risk, since each ovulation cycle is a chance for DNA damage at the site of follicular rupture — and with BRCA1/BRCA2 mutations or Lynch syndrome. Risk falls with anything that suppresses ovulation: prior pregnancy, breastfeeding, and oral contraceptive use.
- Ovarian cancer is often called a "silent killer" because early-stage disease rarely causes symptoms — by the time it presents (bloating, early satiety, pelvic pressure), it has frequently already spread within the peritoneal cavity, which is part of why it carries the worst prognosis of the major gynecologic cancers.
| Category | Representative tumors | High-yield points |
|---|---|---|
| Epithelial (~most common overall, older women) | Serous and mucinous cystadenoma/cystadenocarcinoma; endometrioid; Brenner; clear cell | Serous carcinoma is the most common malignant ovarian tumor and classically shows psammoma bodies (concentric calcified whorls) on histology; mucinous carcinoma can cause pseudomyxoma peritonei; Brenner tumors are usually benign, with a distinctive "coffee bean" nuclear groove on urothelial-like epithelium; CA-125 tracks epithelial tumors, especially serous, but isn't sensitive enough for population screening |
| Germ cell (younger women/children) | Mature teratoma (dermoid — benign, most common germ cell tumor), immature teratoma (malignant), dysgerminoma (ovarian analog of testicular seminoma), yolk sac/endodermal sinus tumor (produces AFP), choriocarcinoma (produces β-hCG) | Dysgerminoma is exquisitely radiosensitive; yolk sac tumor and choriocarcinoma are identified by their tumor markers |
| Sex cord–stromal | Granulosa-theca cell tumor (the most common malignant sex cord–stromal tumor; estrogen-secreting → can cause precocious puberty or postmenopausal bleeding/endometrial hyperplasia; histology shows Call-Exner bodies, small rosette-like clusters resembling primordial follicles; tracked with serum inhibin), thecoma (usually benign, also estrogen-secreting → postmenopausal bleeding), Sertoli-Leydig cell tumor (androgen-secreting → virilization), fibroma (Meigs syndrome: ascites + pleural effusion) | Think "functional/hormonal" tumors — clinical presentation is driven by the hormone secreted, not by mass effect |
| Metastatic | Krukenberg tumor | Bilateral ovarian metastases with signet-ring cells, classically from a gastric primary |
Ovarian tumor category predicts which marker to order: epithelial tumors are tracked with CA-125, germ cell tumors with AFP/β-hCG, and sex cord-stromal tumors announce themselves hormonally rather than through a lab marker at all — knowing the category tells you what to check.
Cervical Neoplasia — A Progression, Not a Single Event
- Risk factors converge on persistent high-risk HPV exposure: early coitarche, multiple partners, immunosuppression, smoking (a cervical-specific cofactor).
- Squamous cell carcinoma is the dominant histology; adenocarcinoma is less common but not HPV-independent.
- Invasive disease spreads laterally through the parametrium before it spreads far by blood — this pattern lets it compress the ureters as they run nearby, causing hydronephrosis and, eventually, renal failure if bilateral and untreated.
Non-neoplastic Uterine Conditions
| Condition | Key features |
|---|---|
| Adenomyosis | Endometrial glands/stroma growing into the myometrium (rather than outside the uterus, as in endometriosis). Presents with abnormal bleeding and dysmenorrhea, with a diffusely enlarged, soft ("boggy"), tender uterus on exam. |
| Endometrial hyperplasia | Excessive proliferation of endometrial glands, almost always driven by estrogen that isn't being opposed by adequate progesterone — obesity, chronic anovulation (PCOS), and unopposed estrogen/tamoxifen therapy are classic settings. Presents with abnormal bleeding; hyperplasia with nuclear atypia carries meaningful risk of progressing to endometrial carcinoma. |
| Endometritis | Infection/inflammation of the endometrium, most often following delivery when vaginal flora ascend into the uterine cavity — a prior C-section is the strongest risk factor. Presents with fever, uterine tenderness, and foul-smelling lochia. |
| Intrauterine adhesions (Asherman syndrome) | Scar tissue within the endometrial cavity, usually following an aggressive dilation and curettage that damages the basal endometrial layer. Presents with reduced/absent menses, infertility, and recurrent pregnancy loss. |
Adenomyosis and endometriosis are the same ectopic-endometrial-tissue process in two different locations — inside the myometrium (adenomyosis, a diffusely boggy uterus) versus outside the uterus entirely (endometriosis, focal implants and chocolate cysts) — which is why they present so differently despite sharing a mechanism.
Uterine Body Tumors
| Tumor | Key features |
|---|---|
| Leiomyoma (fibroid) | Benign smooth muscle tumor — the most common tumor in women overall; estrogen-sensitive (grows in pregnancy, regresses after menopause) |
| Leiomyosarcoma | Malignant; arises de novo rather than from a preexisting fibroid — rare |
| Endometrial carcinoma | Most common gynecologic malignancy overall; strongly linked to unopposed/excess estrogen exposure (nulliparity, obesity, PCOS, tamoxifen, exogenous unopposed estrogen); presents early with postmenopausal bleeding, which is why it is usually caught at a favorable stage |
Vulvar & Vaginal Tumors
- Squamous cell carcinoma of the vulva: HPV-related pathway (younger patients) vs. chronic vulvar dermatosis pathway (older patients, HPV-independent).
- Extramammary Paget disease of the vulva: intraepithelial adenocarcinoma cells in the epidermis — unlike breast Paget disease, usually not associated with an underlying invasive carcinoma.
- Clear cell adenocarcinoma of the vagina: linked to in utero diethylstilbestrol (DES) exposure — a classic teratogen-cancer link.
- Sarcoma botryoides (embryonal rhabdomyosarcoma): grape-cluster mass protruding from the vagina in young girls (<5 years).
Non-neoplastic Vulvar & Vaginal Conditions
| Condition | Key features |
|---|---|
| Bartholin cyst/abscess | Blockage of a Bartholin gland duct causes fluid to accumulate; can become secondarily infected and abscess. Occurs in reproductive-age women. |
| Lichen sclerosus | A chronic inflammatory condition producing thin, porcelain-white plaques that can erode or ulcerate, sometimes extending around the anus in a figure-eight pattern. More common in prepubertal and peri-/postmenopausal women. Presents with intense itching, painful intercourse, and dysuria; benign but carries a modest increased risk of squamous cell carcinoma. |
| Lichen simplex chronicus | Thickened, leathery vulvar skin from chronic rubbing/scratching — a reactive hyperplasia. Benign, with no increased cancer risk (unlike lichen sclerosus). |
| Imperforate hymen | The hymen fails to open centrally. Vaginal secretions can accumulate at birth, causing a bulge that often resolves on its own; if unrecognized, menstrual blood accumulates behind it after puberty (hematocolpos), causing primary amenorrhea and cyclic pelvic pain. |
Lichen sclerosus and lichen simplex chronicus are easy to mix up by name alone: sclerosus is the one with malignant potential (chronic inflammation, porcelain-white atrophy), while simplex chronicus is a purely reactive thickening from scratching, with no increased cancer risk.
Extragonadal Germ Cell Tumors
- Germ cell tumors can occasionally arise outside the gonads, in the midline structures the primordial germ cells pass through during their migration to the genital ridge — most often the retroperitoneum, mediastinum, or pineal/suprasellar region in adults.
- In infants and young children, the most common of these is the sacrococcygeal teratoma.
🎗️ Breast Pathology
BRCA1/2 mutations raise risk for both breast and ovarian cancer through the same defective DNA-repair mechanism — the ovarian side of that shared risk (plus its own ovulation-based risk model) is covered in Gynecologic Neoplasms → Ovarian Tumors — Organize by Cell of Origin.
Benign Breast Disease
| Condition | Features |
|---|---|
| Fibrocystic change | Most common benign breast condition; hormonally driven, cyclic tenderness, often bilateral "blue-dome" cysts; malignant risk only if biopsy shows atypical/proliferative features such as sclerosing adenosis or epithelial hyperplasia with atypia — a simple cyst alone carries no increased risk |
| Fibroadenoma | Most common breast mass in women under 25; well-circumscribed, mobile, rubbery, estrogen-sensitive (can enlarge in pregnancy) — not a cancer precursor |
| Phyllodes tumor | A large, fast-growing fibroepithelial mass with "leaf-like" connective tissue projections on histology, typically presenting in a woman's 40s-50s (older than the typical fibroadenoma patient); most are benign, but a subset behaves malignantly |
| Intraductal papilloma | Benign ductal tumor presenting with unilateral nipple discharge (serous or bloody) — the most common cause of pathologic nipple discharge |
| Fat necrosis | A benign, often painless lump following breast trauma (including surgery) — up to half of patients don't recall a specific injury; can mimic carcinoma on exam/mammography (calcification), so biopsy showing necrotic fat and giant cells is reassuring |
| Mammary duct ectasia | Dilation and inflammation of the subareolar ducts, associated with smoking; presents with thick, often multicolored nipple discharge, periareolar mass, and sometimes nipple retraction |
| Acute (lactational) mastitis | S. aureus entering through nipple fissures, classically during breastfeeding; treated with antibiotics, and breastfeeding/pumping should continue through treatment to keep the duct clear |
Breast Carcinoma — In Situ vs. Invasive
- Distinction hinges on whether tumor cells have breached the basement membrane.
- Ductal carcinoma in situ: confined within the duct; comedo subtype shows central caseous-type necrosis; can progress to invasive disease if untreated.
- Lobular carcinoma in situ: often an incidental biopsy finding rather than a palpable mass; a strong marker of increased future breast cancer risk in either breast, more than a direct precursor lesion.
- Invasive ductal carcinoma is the most common breast malignancy overall.
- Invasive lobular carcinoma classically infiltrates in a single-file pattern due to loss of the E-cadherin adhesion protein; more often multicentric/bilateral.
- Paget disease of the nipple: eczematous nipple/areolar change from malignant cells tracking up the ductal system — essentially always signals an underlying ductal carcinoma (unlike the vulvar counterpart).
- Inflammatory breast cancer: dermal lymphatic invasion causes peau d'orange skin changes; an aggressive presentation that can mimic mastitis.
DCIS is a true precursor that can progress to invasive cancer if untreated, while LCIS mainly functions as a risk marker for future cancer in either breast — that difference is why DCIS is treated locally (excision/radiation) but LCIS is often managed with surveillance or risk-reduction rather than resection.
- Early menarche, late menopause, nulliparity, obesity (postmenopausal)
- Genetic: BRCA1/2, first-degree relative with breast cancer
- Hormone-receptor status guides therapy: ER/PR-positive tumors respond to antiestrogen strategies (tamoxifen, aromatase inhibitors); HER2 amplification predicts response to HER2-targeted therapy; "triple-negative" tumors (ER-, PR-, and HER2-negative) lack all three targets and tend to behave more aggressively — they're disproportionately more common in Black women and in BRCA1 carriers.
- Epidemiology worth having cold: breast cancer is the most common cancer diagnosed in women, but lung cancer remains the leading cause of cancer death in women — breast cancer is second. Most tumors arise in the upper outer quadrant, which contains the greatest volume of glandular tissue.
- Male breast cancer exists but is rare (roughly 1% of all breast cancer cases); it still carries meaningful BRCA2 association and should not be dismissed when a male patient presents with a breast mass.
♂️ Prostate & Testicular Pathology
BPH and prostate carcinoma are treated by drugs that target the DHT and androgen-signaling pathways named here (finasteride, α1-blockers, GnRH agonists, abiraterone) — their mechanisms are detailed in Reproductive Pharmacology → Hormone Modulators.
Penile Pathology
| Condition | Key features |
|---|---|
| Peyronie disease | A fibrous plaque forms within the tunica albuginea, usually after repeated minor trauma during intercourse, causing an abnormal curvature of the erect penis with pain and possible erectile dysfunction. Distinct from penile fracture, which is an acute tunica albuginea rupture from a single forceful bending injury. |
| Ischemic priapism | A painful erection lasting more than 4 hours that isn't relieved by ejaculation. Associated with sickle cell disease (sickled cells sludge in the venous outflow channels) and certain medications (sildenafil, trazodone). A urologic emergency — prolonged ischemia risks permanent erectile tissue damage, so it's treated promptly with corporal aspiration or intracavernosal phenylephrine. |
| Squamous cell carcinoma of the penis | Uncommon in circumcised populations; associated with HPV-16 and lack of circumcision. Three in-situ precursor lesions are worth distinguishing: Bowen disease (leukoplakia — a white plaque — on the shaft), erythroplasia of Queyrat (erythroplakia — a red plaque — on the glans, the same process in a different location), and Bowenoid papulosis (reddish papules of uncertain malignant potential, often in younger men). |
Benign Prostatic Hyperplasia vs. Prostate Carcinoma
| Feature | BPH | Prostate carcinoma |
|---|---|---|
| Zone affected | Transition zone (periurethral) → obstructive symptoms early | Peripheral zone → often asymptomatic until advanced/palpable on exam |
| Nature | Benign hyperplasia (stromal + glandular); driven by DHT, not a cancer precursor | Malignant adenocarcinoma; most common cancer in men |
| Exam/labs | Smooth, symmetrically enlarged prostate; PSA may be mildly elevated but is not diagnostic | Firm, irregular/nodular prostate; PSA often more substantially elevated; metastasizes preferentially to bone (osteoblastic lesions, especially spine) |
| First-line treatment | α1-blockers (relax prostatic/bladder-neck smooth muscle) ± 5α-reductase inhibitors (shrink gland volume) | Risk-stratified: surveillance, surgery, radiation, or androgen-deprivation therapy for advanced disease |
Zone of origin explains the symptom timeline: BPH starts in the periurethral transition zone and causes obstructive symptoms early, while carcinoma starts peripherally and stays silent until it's large enough to feel on exam or has already spread — this is why a normal DRE never fully excludes prostate cancer.
Prostatitis
- Presents with dysuria, urinary frequency/urgency, low back pain, and a warm, tender, boggy prostate on exam — distinct from the firm/nodular exam of carcinoma.
- Acute bacterial prostatitis: E. coli in older men; consider C. trachomatis/N. gonorrhoeae in younger, sexually active men.
- Chronic prostatitis: may be bacterial (recurrent/inadequately treated infection) or nonbacterial (nerve irritation, chemical/inflammatory causes without a clear organism).
Scrotal Masses — Distinguish by Palpation Findings
| Entity | Contents/mechanism | Distinguishing clue |
|---|---|---|
| Hydrocele | Serous fluid within the tunica vaginalis, from a patent processus vaginalis | Transilluminates |
| Hematocele | Blood within the tunica vaginalis | Usually follows scrotal trauma; does not transilluminate (helps distinguish from hydrocele) |
| Varicocele | Dilated pampiniform plexus veins | "Bag of worms" texture, worsens standing, classically left-sided (drains into the left renal vein at a right angle) — a new right-sided or acute varicocele raises concern for renal vein/IVC obstruction from a mass |
| Spermatocele | Epididymal cyst containing sperm | Separate, cystic, mobile mass above/behind the testis |
| Testicular torsion | Twisting of the spermatic cord compromising blood flow | Sudden severe pain, absent cremasteric reflex — a surgical emergency; necrosis if not corrected quickly |
| Orchitis | Infection/inflammation of the testis itself, viral (e.g., mumps) or bacterial | Testicular pain and swelling; bilateral involvement can result in impaired fertility |
| Epididymitis | Infection/inflammation of the epididymis | In sexually active young men, usually N. gonorrhoeae/C. trachomatis; in older men or after instrumentation, more often coliforms (E. coli); positive Prehn sign (pain relief with scrotal elevation) helps distinguish from torsion |
Transillumination and timing do most of the diagnostic work here: fluid-filled masses (hydrocele, spermatocele) transilluminate and blood/solid masses don't, while sudden severe pain points to torsion and a more gradual course points to infection (epididymitis/orchitis).
Testicular Germ Cell Tumors
- Unlike the ovary, the great majority of testicular tumors are malignant and of germ cell origin.
- Seminoma: most common type; radiosensitive; painless testicular enlargement, typically confined and curable.
- Non-seminomatous tumors (embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma) tend to be more aggressive and often occur as mixed tumors; yolk sac tumor and choriocarcinoma are again marked by AFP and β-hCG respectively.
- Unlike the ovary, a testicular teratoma is treated as malignant regardless of how histologically mature/well-differentiated its tissue looks — the same tumor type behaves very differently depending on which gonad it arises in.
- Sex cord-stromal tumors (Leydig, Sertoli cell) are usually benign and, when functional, present with hormone-driven findings (gynecomastia, precocious puberty); Leydig cell tumors have a distinctive histologic clue — intracytoplasmic Reinke crystals.
- Cryptorchidism raises germ cell tumor risk even after surgical correction — correction reduces but does not eliminate the risk, and also protects the contralateral (normally descended) testis by allowing surveillance.
- Primary testicular lymphoma (usually diffuse large B-cell): not a germ cell tumor at all, but it's the most common testicular malignancy in men over 60 — worth keeping in the differential for a testicular mass in an older man. Often bilateral and aggressive.
| Tumor | β-hCG | AFP |
|---|---|---|
| Seminoma | Occasionally mildly elevated | Normal |
| Choriocarcinoma | Markedly elevated (syncytiotrophoblast-derived) | Normal |
| Yolk sac tumor | Normal | Markedly elevated |
| Embryonal carcinoma | Can be mildly elevated | Normal if pure, elevated if mixed with yolk sac elements |
Because hCG and TSH share a structurally identical α-subunit, a very high hCG (as in choriocarcinoma) can weakly stimulate the TSH receptor and produce symptoms of hyperthyroidism.
🩸 Menstrual & Ovulatory Disorders
PCOS's hyperinsulinemia-driven excess theca androgen production is a distortion of the normal two-cell, two-gonadotropin division of labor between theca and granulosa cells explained in Menstrual Cycle & Hormonal Axis → The HPO Axis, Step by Step.
Abnormal Uterine Bleeding — Causes by Category
The formal classification system (PALM-COEIN) splits causes into structural (Polyp, Adenomyosis, Leiomyoma, Malignancy/hyperplasia) and nonstructural (Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not-yet-classified) categories — grouped here by that same underlying logic.
- Structural: polyps, leiomyomas (fibroids), adenomyosis
- Ovulatory dysfunction: anovulatory cycles (extremes of reproductive age, PCOS)
- Coagulopathy: von Willebrand disease, especially in adolescents
- Neoplastic: endometrial hyperplasia/carcinoma — always must be excluded in a woman >45 or with risk factors
- Pregnancy-related: miscarriage, ectopic pregnancy
- Iatrogenic: anticoagulants, IUDs, hormonal therapy
Polycystic Ovary Syndrome (PCOS)
- Diagnosis (Rotterdam-style, 2 of 3): oligo/anovulation, clinical or biochemical hyperandrogenism, polycystic ovarian morphology on ultrasound.
- Core mechanism: insulin resistance → hyperinsulinemia → amplifies LH-driven theca androgen production and lowers hepatic SHBG (raises free androgen) → disrupted follicular maturation.
- Labs: LH/FSH ratio elevated, mildly elevated testosterone/DHEAS, chronic unopposed estrogen (from anovulation) predisposes to endometrial hyperplasia.
- Management principle: address the underlying insulin resistance (weight loss, metformin) and tailor hormonal therapy to whether the patient desires fertility (ovulation induction) or not (combined contraceptives/progestin, antiandrogens for hirsutism).
PCOS's elevated LH/FSH ratio and low SHBG aren't independent findings — both trace back to the same hyperinsulinemia, which directly amplifies theca-cell androgen synthesis and suppresses hepatic SHBG production, so the two labs are two readouts of one upstream driver.
Endometriosis
- Ectopic endometrial glands/stroma outside the uterine cavity, most often on the ovaries, that respond to cyclic hormonal signals just like eutopic endometrium.
- Cyclic bleeding into a closed space → hemosiderin-laden "chocolate cyst" (endometrioma), fibrosis, adhesions.
- Classic presentation: cyclic pelvic pain worst just before/during menses, dyspareunia, infertility.
- Definitive diagnosis is surgical/laparoscopic visualization; medical management suppresses ovulation (hormonal contraceptives, GnRH agonists) to reduce cyclic stimulation.
Approach to Amenorrhea
| Level of defect | Representative causes | Typical labs |
|---|---|---|
| Hypothalamic | Functional (stress, excessive exercise, low body weight/anorexia) | Low/normal FSH, LH, estrogen |
| Pituitary | Prolactinoma, Sheehan syndrome | High prolactin suppresses GnRH pulsatility |
| Ovarian | Primary ovarian insufficiency, PCOS | High FSH/LH (insufficiency) — hypergonadotropic hypogonadism |
| Uterine/outflow | Asherman syndrome (intrauterine adhesions), cervical stenosis | Normal hormones — a progestin challenge fails to produce withdrawal bleeding despite an intact axis |
Functional Ovarian Cysts
Usually asymptomatic incidental findings, but can rupture, bleed, or predispose to adnexal torsion.
| Cyst type | Mechanism |
|---|---|
| Follicular cyst | The most common ovarian mass in young women — a mature follicle fails to rupture at ovulation. Usually resolves on its own; can transiently oversecrete estrogen. |
| Corpus luteal cyst | The corpus luteum fails to involute after ovulation. Usually self-resolving; can oversecrete progesterone. |
| Theca lutein cyst | Driven by excess hCG stimulation — often bilateral and multiple. A red flag for gestational trophoblastic disease (molar pregnancy, choriocarcinoma). |
Primary Dysmenorrhea
- Painful menses driven by prostaglandin-mediated uterine contractions that transiently reduce endometrial blood flow (ischemic pain) — a normal physiologic process taken to an uncomfortable extreme, not a sign of underlying pelvic pathology.
- First-line treatment is an NSAID (directly targets the prostaglandin synthesis driving the pain) or hormonal contraception (suppresses ovulation and thins the endometrium).
- Distinguish from secondary dysmenorrhea, where pain is caused by an identifiable lesion such as endometriosis, adenomyosis, or fibroids.
Primary Ovarian Insufficiency, Expanded
- Premature depletion/atresia of ovarian follicles causing a menopause-like state before age 40, in someone who has already gone through puberty.
- Most cases are idiopathic, but it's worth a karyotype and autoimmune workup — it's associated with chromosomal abnormalities (Turner syndrome, the fragile X premutation) and autoimmune oophoritis.
- Labs mirror menopause: low estrogen with compensatory high LH and (especially) high FSH.
🕰️ Menopause & Hormone Therapy
FSH rising first and most as follicles deplete is the same negative-feedback loop described for the normal cycle in Menstrual Cycle & Hormonal Axis → The HPO Axis, Step by Step — menopause is that loop running with an exhausted follicle pool instead of a normal one.
- Defined retrospectively after 12 consecutive months of amenorrhea; average age ~51.
- Mechanism: depletion of the finite ovarian follicle pool → falling estrogen/inhibin → loss of negative feedback → FSH rises first and most (used as the lab marker).
Early/Vasomotor Symptoms
- Hot flashes, night sweats
- Mood lability, sleep disruption
- Irregular cycles preceding cessation
Late/Chronic Consequences of Estrogen Loss
- Genitourinary syndrome of menopause: vaginal atrophy, dryness, dyspareunia, recurrent UTIs
- Accelerated bone loss → osteoporosis (loss of estrogen's suppression of osteoclast activity)
- Adverse lipid shift (↓HDL) → increased cardiovascular risk
Hormone Replacement Therapy — Balancing Benefit and Risk
- Effective for vasomotor symptoms and genitourinary atrophy; reduces fracture risk.
- Unopposed estrogen is contraindicated with an intact uterus — must add a progestin to prevent endometrial hyperplasia/carcinoma; estrogen alone is appropriate only post-hysterectomy.
- Increased risk with combined therapy: venous thromboembolism, stroke, and (with long-duration combined use) breast cancer.
- Contraindicated in a personal history of hormone-sensitive cancer, active liver disease, or unexplained vaginal bleeding.
The opposed-vs-unopposed estrogen rule comes down to one organ: a uterus present means unopposed estrogen unacceptably raises endometrial cancer risk, so a progestin must be added; no uterus (post-hysterectomy) removes that risk entirely, so estrogen alone is preferred.
🦠 Sexually Transmitted Infections
Silent chlamydial/gonococcal PID's tubal scarring is the same tubal-damage mechanism that drives ectopic pregnancy risk, discussed in Pregnancy, Placenta & Complications → Ectopic Pregnancy.
Genital Ulcer Disease — Painful vs. Painless
| Organism | Disease | Ulcer character |
|---|---|---|
| Herpes simplex virus-2 | Genital herpes | Multiple, shallow, painful vesicles/ulcers |
| Haemophilus ducreyi | Chancroid | Painful ulcer with ragged borders, often with tender suppurative lymphadenopathy |
| Treponema pallidum | Primary syphilis | Painless, indurated chancre |
| Chlamydia trachomatis (L1–L3) | Lymphogranuloma venereum | Transient painless ulcer followed by painful lymphadenopathy |
| Klebsiella granulomatis | Granuloma inguinale (donovanosis) | Painless, beefy-red, friable ulcer; biopsy shows intracytoplasmic Donovan bodies |
Pain is the fastest way to sort genital ulcers into two buckets — painful (HSV, chancroid) versus painless (syphilis, LGV's initial lesion, granuloma inguinale) — and from there, ulcer character and the lymphadenopathy pattern narrow it further.
Cervicitis / PID Organisms & Other Common STIs
| Organism | Disease pattern |
|---|---|
| Neisseria gonorrhoeae | Urethritis, cervicitis, PID; can disseminate to cause a septic monoarticular arthritis with pustular skin lesions |
| Chlamydia trachomatis (D–K serotypes) | Most common bacterial STI overall; often asymptomatic, major preventable cause of tubal-factor infertility from silent PID |
| HPV 6/11 | Condyloma acuminata (genital warts) — low oncogenic risk |
| HPV 16/18 (also 31/33/45) | High oncogenic risk — driver of cervical, vulvar, vaginal, anal, and penile squamous carcinoma via E6/E7 oncoprotein inactivation of p53 and Rb |
| Trichomonas vaginalis | Frothy, malodorous discharge; motile flagellated protozoan on wet mount |
Genitourinary Infections That Are Not Sexually Transmitted
- Candida albicans vulvovaginitis: thick, curd-like discharge, often precipitated by antibiotic use, diabetes, or pregnancy rather than by sexual contact.
- Escherichia coli and Staphylococcus saprophyticus: leading causes of community-acquired urinary tract infection, arising from periurethral/fecal flora rather than transmission.
- Toxic shock syndrome: caused by Staphylococcus aureus exotoxin acting as a superantigen — it cross-links MHC class II and the T-cell receptor outside the normal antigen-binding groove, causing massive nonspecific T-cell activation and a cytokine storm; classically associated with prolonged tampon use, but can also follow any focal staphylococcal colonization/infection (wounds, nasal packing).
🔬 Gynecologic Diagnostic Tests
Koilocytes on Pap smear are the cytologic signature of the same HPV effect that drives the CIN I→III→invasive carcinoma progression detailed in Gynecologic Neoplasms → Cervical Neoplasia — A Progression, Not a Single Event.
| Test | Principle | Finding → Diagnosis |
|---|---|---|
| Saline wet mount | Vaginal secretions viewed directly under saline | Motile flagellated organisms → Trichomonas; epithelial cells stippled with adherent bacteria (clue cells) → bacterial vaginosis |
| KOH prep | KOH lyses human cells, leaving fungal elements intact; also releases a fishy amine odor from bacterial vaginosis | Budding yeast with pseudohyphae → Candida; positive "whiff test" → bacterial vaginosis |
| Pap smear | Cytology of exfoliated cervical cells | Perinuclear halo cells (koilocytes) → HPV effect/dysplasia; screens for cervical intraepithelial neoplasia and carcinoma |
Wet mount, KOH prep, and Pap smear each interrogate a different layer of the sample — live motile organisms, fungal cell walls resistant to KOH lysis, and exfoliated cell morphology, respectively — which is why an unclear vaginitis case sometimes needs more than one run in parallel.
💉 Reproductive Pharmacology
Leuprolide's flip from stimulating to suppressing gonadotropins depends on why pulsatile vs. continuous GnRH gives opposite results — that receptor-desensitization logic is explained in Menstrual Cycle & Hormonal Axis → The HPO Axis, Step by Step.
Hormone Modulators
| Drug class / example | Mechanism | Use | Notable adverse effect |
|---|---|---|---|
| Clomiphene | Selective estrogen receptor modulator — blocks estrogen's negative feedback at the hypothalamus/pituitary | Ovulation induction in infertility | Ovarian hyperstimulation, multiple gestation, visual disturbance |
| Flutamide, bicalutamide | Nonsteroidal antiandrogens — competitive androgen receptor blockers | Metastatic/advanced prostate cancer, usually alongside GnRH-analog therapy | Gynecomastia, hepatotoxicity |
| Ketoconazole (antiandrogen use) | At high doses, inhibits adrenal and gonadal steroid synthesis (in addition to its antifungal ergosterol-inhibition mechanism) | Prostate carcinoma (largely historical, second-line); fungal infections | Hepatotoxicity, strong CYP450 inhibitor (major drug-interaction risk), gynecomastia |
| Methyltestosterone | Androgen receptor agonist | Male hypogonadism/delayed puberty | Testicular atrophy (via suppression of endogenous LH → reduced intratesticular testosterone), premature epiphyseal closure/stunted growth if given before growth completion, masculinization if used in females |
| Tamoxifen | SERM — antagonist at breast tissue, partial agonist at endometrium | ER-positive breast cancer treatment/prevention | Endometrial hyperplasia/cancer risk, hot flashes, thromboembolism |
| Raloxifene | SERM — antagonist at breast and endometrium, agonist at bone | Osteoporosis prevention with a lower endometrial cancer risk than tamoxifen | Thromboembolism, hot flashes |
| Aromatase inhibitors (e.g., anastrozole) | Block peripheral conversion of androgens to estrogen | Postmenopausal ER-positive breast cancer | Bone loss, arthralgia |
| Leuprolide (GnRH analog) | Pulsatile dosing mimics natural GnRH → stimulates gonadotropins; continuous dosing desensitizes the receptor → suppresses gonadotropins | Pulsatile: infertility. Continuous: prostate cancer, endometriosis, fibroids, precocious puberty | Initial "flare" of hormone before suppression; hypoestrogenic/hypoandrogenic symptoms |
| Finasteride | 5α-reductase inhibitor — blocks testosterone → DHT conversion | BPH, male-pattern baldness | Decreased libido, teratogenic (avoid handling by pregnant women) |
| Spironolactone | Antiandrogen (blocks androgen receptor) + aldosterone antagonist | Hirsutism/acne in PCOS | Hyperkalemia, menstrual irregularity, gynecomastia |
| Abiraterone | Inhibits an enzyme (17α-hydroxylase/17,20-lyase) needed for androgen synthesis in the testis, adrenal gland, and tumor tissue | Metastatic prostate cancer | Hypertension and hypokalemia from the resulting buildup of mineralocorticoid precursors |
| Degarelix | Direct GnRH-receptor antagonist — unlike leuprolide-type agonists, it suppresses gonadotropins immediately, with no initial testosterone "flare" | Prostate cancer | Hot flashes, hepatotoxicity |
| Danazol | Synthetic androgen — partial agonist at the androgen receptor | Endometriosis, hereditary angioedema | Weight gain, acne, hirsutism/masculinization, lowered HDL, hepatotoxicity |
| Minoxidil | Direct arteriolar vasodilator | Androgenetic alopecia (topical); severe refractory hypertension (oral) | Hypertrichosis, reflex tachycardia/fluid retention (oral use) |
| Ulipristal | Selective progesterone-receptor modulator — partial antagonist | Emergency contraception (effective later in the cycle than levonorgestrel, since it can still blunt an LH surge already in progress) | Headache, nausea, abdominal pain |
Most of this table splits into two logics: block synthesis (ketoconazole, abiraterone, finasteride, aromatase inhibitors) versus block the receptor (flutamide, bicalutamide, spironolactone, tamoxifen/raloxifene, mifepristone) — knowing which lever a drug pulls predicts its hormonal side-effect profile.
Anabolic-Androgenic Steroid Abuse
- Exogenous testosterone derivatives increase muscle mass, strength, and recovery, but chronic use suppresses the hypothalamic-pituitary-gonadal axis the same way any external androgen does — negative feedback drives GnRH, LH, and FSH down, which in turn shuts down endogenous testosterone production and spermatogenesis.
- Suspect it in a young man presenting with the combination of infertility, unusually high muscle mass, small/atrophic testes, and gynecomastia (from peripheral aromatization of the excess androgen to estrogen) — small testes plus high muscle bulk is the tell, since natural high testosterone wouldn't shrink the testes.
- Other effects: acne, aggression/mood swings ("roid rage"), polycythemia, an adverse LDL/HDL shift that raises cardiovascular risk, premature epiphyseal closure in adolescent users, and hepatotoxicity (including hepatic adenoma) — particularly with orally active agents.
- In females: virilization (hirsutism, voice changes, clitoromegaly), menstrual irregularity, and decreased breast size.
- Recovery of the axis after stopping is typically slow, since the pituitary and testes both need time to resensitize.
Small testes plus visibly high muscle mass is the exam tell precisely because it's paradoxical — endogenous testosterone from a physiologic source would never shrink the testes, only exogenous androgen (suppressing LH/FSH via negative feedback) does that while still building muscle.
Uterotonics & Tocolytics
Erectile Dysfunction Agents
- PDE-5 inhibitors (sildenafil, vardenafil, tadalafil): prevent breakdown of cGMP → sustained smooth muscle relaxation and corporal blood flow.
- Absolute contraindication: concurrent nitrate use — combined nitric-oxide-pathway potentiation can cause severe, potentially fatal hypotension.
- Other adverse effects: headache, flushing, blue-tinged vision (transient PDE-6 cross-inhibition), priapism.
⚠️ Congenital & Intersex Anomalies
AIS and 5α-reductase deficiency only make sense as a pair against the "testosterone masculinizes the ducts, DHT masculinizes the external genitalia" split established in Sexual Determination & Development → External Genitalia.
Penile/Urethral Anomalies
| Condition | Defect | Association |
|---|---|---|
| Hypospadias | Urethral meatus opens on the ventral penile shaft; failure of urogenital fold fusion | More common of the two; screen for other GU defects |
| Epispadias | Urethral meatus opens on the dorsal shaft; genital tubercle mispositioning | Bladder exstrophy |
Quick anchor: "ventral-hypo, dorsal-epi" — ventral starts with a consonant like hypospadias' h, dorsal pairs with epispadias' higher position.
Hypospadias and epispadias are named for where the urethral opening ends up relative to the embryologic fold that failed to close — ventral fold failure gives hypospadias, dorsal genital-tubercle mispositioning gives epispadias — which is also why epispadias travels with bladder exstrophy and hypospadias usually doesn't.
Disorders of Sex Development (Intersex Conditions)
| Condition | Karyotype | Mechanism | Key features |
|---|---|---|---|
| Congenital adrenal hyperplasia (21-hydroxylase deficiency) | 46,XX | Excess adrenal androgen exposure in utero | Virilized female genitalia; low cortisol/aldosterone, high ACTH; salt-wasting form |
| Androgen insensitivity syndrome | 46,XY | Defective androgen receptor — cells cannot respond to testosterone or DHT | Female external phenotype, blind-ending vagina, absent uterus (AMH still works normally), testes present (often intra-abdominal/inguinal), scant/absent pubic and axillary hair |
| 5α-reductase deficiency | 46,XY | Cannot convert testosterone → DHT | Ambiguous/female-appearing genitalia at birth, but Wolffian structures develop normally (testosterone intact); virilization at puberty (testosterone surge overcomes the enzyme defect) |
| True gonadal intersex | Variable (often 46,XX) | Both ovarian and testicular tissue present in the same individual | Ambiguous genitalia; rare |
Aromatase Deficiency — the Mirror Image of AIS
- An autosomal recessive inability to synthesize estrogen. Fetal adrenal androgens that would normally be aromatized to estrogen by the placenta instead spill over and get converted to testosterone peripherally.
- Because fetal androgens can cross the placenta, this virilizes both a 46,XX female fetus (atypical genitalia at birth) and the mother carrying it (acne, hirsutism during that pregnancy) — a useful two-patient clue that distinguishes it from a fetal-only process like CAH.
Working Out a DSD From Labs and Exam Findings
| Testosterone | LH | Points to |
|---|---|---|
| High | High | Androgen insensitivity syndrome (receptor is unresponsive, so feedback inhibition fails and both rise) |
| High | Low | An androgen-secreting tumor, or exogenous anabolic steroid use (external testosterone suppresses LH) |
| Low | High | Primary (hypergonadotropic) hypogonadism — the gonad itself has failed |
| Low | Low | Secondary (hypogonadotropic) hypogonadism — the hypothalamus/pituitary isn't driving the gonad |
| Uterus present? | Breasts present? | Points to |
|---|---|---|
| Yes | No | Hypergonadotropic or hypogonadotropic hypogonadism in a genotypic female — estrogen never rose enough to develop breasts, but the Müllerian ducts were never suppressed |
| No | Yes | Müllerian agenesis in a genotypic female (ovaries make estrogen normally, so breasts develop, but the uterus never formed) — or androgen insensitivity syndrome in a genotypic male (testes make estrogen via peripheral aromatization, and AMH still suppressed the uterus) |
These two tables run as one algorithm in sequence: the testosterone/LH pattern tells you whether the problem is receptor-based, tumor/exogenous, or an HPG-axis failure, and uterus/breast status then tells you whether Müllerian structures were ever suppressed — together they localize the defect without needing a karyotype first.
Naming Convention You'll See on Older Exam Material
- These older labels are organized by gonadal sex, not by the appearance of the external genitalia:
- Female pseudohermaphroditism: ovaries are present (46,XX), but external genitalia are virilized by androgen excess — the CAH picture above is the classic example.
- Male pseudohermaphroditism: testes are present (46,XY), but external genitalia are incompletely masculinized because of deficient testosterone/AMH action — AIS and 5α-reductase deficiency both fall under this umbrella.
- True hermaphroditism (distinct from either "pseudo" category): both ovarian and testicular tissue coexist in the same individual, with genuinely ambiguous genitalia — rare, usually 46,XX.
- Memory hook: "pseudo" means the gonads are unambiguously one sex — only the external appearance is ambiguous; "true" hermaphroditism means the gonadal tissue itself is mixed.
Uterine Fusion Defects
- Caused by incomplete fusion of the paired paramesonephric ducts.
- Spectrum: septate uterus (persistent internal septum) → bicornuate uterus (only the upper/superior portion fails to fuse) → uterus didelphys (complete failure, duplicated uterus/cervix).
- Associated with recurrent pregnancy loss and malpresentation.
Hypogonadotropic Syndromes
- Kallmann syndrome: failure of GnRH-neuron migration from the olfactory placode → isolated GnRH deficiency → low FSH/LH → absent puberty.
- Classic pairing: anosmia (or hyposmia) + failure of pubertal development — the olfactory bulb defect is a developmental marker, not the cause of the endocrine problem.
Testicular/Inguinal Anomalies
- Cryptorchidism: failure of testicular descent; most resolve by 1 year; persistent cases carry increased risk of infertility and germ-cell malignancy (even after later orchiopexy).
- Congenital (indirect) inguinal hernia: patent processus vaginalis allows bowel to herniate alongside the spermatic cord; strongly linked to cryptorchidism.
🧫 Chromosomal Syndromes
Turner syndrome's streak gonads produce the same hypergonadotropic (high FSH/LH, low estrogen) lab pattern used to work up ovarian-level causes of amenorrhea in Menstrual & Ovulatory Disorders → Approach to Amenorrhea.
Grouped here because advanced maternal age is a shared risk driver and these are reliably tested alongside reproductive/prenatal topics — not because they are reproductive-organ disease per se.
Autosomal Trisomies — Ranked by Frequency at Birth
| Syndrome | Karyotype | Signature features |
|---|---|---|
| Down syndrome | Trisomy 21 (nondisjunction, most cases); ~4% Robertsonian translocation (not age-related) | Flat facial profile, upslanting palpebral fissures, single palmar crease, hypotonia; increased risk of AV-canal heart defects, early Alzheimer pathology, ALL |
| Edwards syndrome | Trisomy 18 | Clenched fists with overlapping fingers, rocker-bottom feet, micrognathia, severe growth restriction; most die in infancy |
| Patau syndrome | Trisomy 13 | Midline defects — cleft lip/palate, holoprosencephaly, polydactyly, microphthalmia |
| Cri du chat syndrome | Deletion of chromosome 5p | High-pitched, cat-like cry in infancy, microcephaly, widely spaced eyes (hypertelorism), intellectual disability |
Sex Chromosome Aneuploidies
| Syndrome | Karyotype | Features |
|---|---|---|
| Turner syndrome | 45,X | Short stature, webbed neck, shield chest, streak gonads → 1° amenorrhea, coarctation of the aorta, bicuspid aortic valve, horseshoe kidney. Falling estrogen removes negative feedback, so both LH and FSH rise (FSH more markedly) — effectively menopause before menarche. |
| Klinefelter syndrome | 47,XXY | Tall, long limbs, small firm testes, gynecomastia, infertility (seminiferous tubule hyalinization); dysfunctional Sertoli cells → ↓inhibin B → ↑FSH, and dysfunctional Leydig cells → ↓testosterone → ↑LH |
| XYY | 47,XYY | Tall, usually phenotypically unremarkable otherwise; historically (and controversially) linked to behavioral impulsivity |
| Triple X | 47,XXX | Usually clinically silent; mild learning differences possible |
Turner and Klinefelter both raise gonadotropins, but through opposite gonadal failures — Turner's streak gonads make almost no sex steroid or inhibin at all, while Klinefelter's dysfunctional Sertoli and Leydig cells separately fail to make inhibin B and testosterone — which is why FSH and LH both end up elevated in each syndrome.
Repeat-Expansion & Imprinting Disorders
- Fragile X syndrome: CGG trinucleotide repeat expansion, X-linked; large jaw/ears, long face, macroorchidism after puberty; second most common genetic cause of intellectual disability overall (most common inherited cause — trisomy 21 is more common overall but usually non-inherited).
- Prader-Willi syndrome: deletion of paternal 15q11–13 (only the paternal copy is normally expressed here) → hyperphagia/obesity, hypotonia, hypogonadism.
- Angelman syndrome: deletion of the same region but on the maternal allele → ataxic gait, seizures, inappropriate laughter.
🗺️ Reproductive Anatomy
The left gonadal vein's longer, sharper-angled drainage route into the left renal vein explained here is the anatomic basis for why varicoceles are overwhelmingly left-sided, discussed clinically in Prostate & Testicular Pathology → Scrotal Masses — Distinguish by Palpation Findings.
Venous & Lymphatic Drainage
- The right ovarian/testicular vein drains directly into the IVC. The left ovarian/testicular vein takes a longer route, draining first into the left renal vein before reaching the IVC — this asymmetry, combined with the left vein entering the renal vein at a sharper angle, is why varicoceles are overwhelmingly left-sided (see the male pathology section).
- Lymphatic drainage follows embryologic origin rather than final adult position:
- Ovaries, fallopian tubes, and the uterine fundus (structures that started high in the abdomen) → para-aortic nodes.
- Body of the uterus and cervix → external iliac nodes.
- Cervix and proximal vagina (and, in males, the prostate) → internal iliac nodes.
- Distal vagina and vulva (and, in males, the scrotum) → superficial inguinal nodes, since these structures develop from external genital tissue.
- Glans of the clitoris/penis → deep inguinal nodes.
- Testes drain to the para-aortic nodes (not the inguinal nodes) because they, too, originate high in the abdomen before descending — an important exception when staging testicular cancer.
Lymphatic drainage follows where a structure started in development, not where it ends up in the adult — that single rule predicts every entry in this list, including why the testis, which starts high in the abdomen, drains to the para-aortic nodes instead of the inguinal nodes its final scrotal position would suggest.
Ligaments Supporting the Uterus & Ovary
| Ligament | Connects | Carries | Why it matters |
|---|---|---|---|
| Infundibulopelvic (suspensory) ligament | Ovary to the pelvic side wall | Ovarian vessels | Ligating it during an oophorectomy risks injuring the ureter, which runs close by |
| Utero-ovarian ligament | Ovary to the uterine horn | — | A gubernaculum remnant |
| Round ligament | Uterine horn to the labia majora | — | Also a gubernaculum remnant; travels through the inguinal canal |
| Broad ligament | Uterus to the pelvic side wall | Ovary, fallopian tube, round ligament | A peritoneal fold, not a true ligament — made up of the mesometrium, mesovarium, and mesosalpinx |
| Cardinal ligament | Cervix to the pelvic side wall | Uterine vessels | Ligating it during a hysterectomy is another point of ureteral injury risk ("water under the bridge" — the ureter passes just beneath the uterine artery here) |
| Uterosacral ligament | Cervix to the sacrum | — | Provides apical support; laxity here contributes to pelvic organ prolapse |
Adnexal Torsion & Pelvic Organ Prolapse
- Adnexal torsion: the ovary and tube twist around the infundibulopelvic and utero-ovarian ligaments, compressing the low-pressure venous/lymphatic outflow first while arterial inflow continues — this produces ovarian edema that eventually chokes off arterial supply too, leading to necrosis if not corrected. Usually occurs in an ovary enlarged by a cyst or mass; presents with acute pelvic pain, nausea/vomiting, and an adnexal mass, and is a surgical emergency.
- Pelvic organ prolapse: herniation of pelvic organs toward or through the vaginal walls, associated with multiparity, aging, and obesity (all of which weaken pelvic floor support). Classified by which compartment bulges: anterior (bladder — cystocele, the most common), posterior (rectum — rectocele, or small bowel — enterocele), or apical (uterus, cervix, or vaginal vault itself). Presents with pelvic pressure/bulging, urinary frequency, constipation, and sexual dysfunction; procidentia describes prolapse severe enough to involve all three compartments.
Epithelial Lining, Segment by Segment
| Structure | Epithelium |
|---|---|
| Vulva, vagina, ectocervix | Stratified squamous (nonkeratinized in the vagina and ectocervix) |
| Transformation zone | The squamocolumnar junction — where ecto- meets endocervix; this is the single most common site for cervical dysplasia/cancer to arise, and is specifically what a Pap smear samples |
| Endocervix | Simple columnar |
| Uterus | Simple columnar with tubular glands; the glands run straight and narrow in the proliferative phase and become coiled/tortuous in the secretory phase |
| Fallopian tube | Simple columnar, ciliated (the cilia help propel the oocyte/embryo toward the uterus) |
| Ovarian surface | Simple cuboidal (the "germinal" epithelium covering the ovary) |
The transformation zone is the one entry in this table worth memorizing above the rest — it's the only place where two epithelial types meet, which is exactly why it's biologically vulnerable to HPV-driven metaplastic change and is specifically what a Pap smear is designed to sample.
Seminiferous Tubules — Who Does What
| Cell type | Role |
|---|---|
| Spermatogonia | The germ cells lining the tubule — maintain the stem-cell pool and give rise to primary spermatocytes |
| Sertoli cells | Non-germ cells lining the tubule — nourish and support developing sperm, form tight junctions that build the blood-testis barrier (shielding developing sperm antigens from the immune system), secrete inhibin B (feeds back to suppress FSH) and androgen-binding protein (keeps local testosterone concentrated), and are the source of anti-Müllerian hormone. They're temperature-sensitive — heat (varicocele, cryptorchidism) impairs their function and lowers sperm counts. Developmentally and functionally, they're the male counterpart of granulosa cells. |
| Leydig cells | Sit in the interstitium between tubules — secrete testosterone in response to LH; unlike Sertoli cells, their hormone output is not temperature-sensitive. They're the male counterpart of theca interna cells. |
Sertoli and Leydig cells are functional mirrors of granulosa and theca cells: Sertoli/granulosa both respond to FSH and secrete inhibin, Leydig/theca both respond to LH and secrete androgen — the same two-cell, two-gonadotropin logic from the female axis maps directly onto testicular physiology.
Where the Sex Steroids Actually Come From
- Estrogens: the ovary makes estradiol (the most potent form), the placenta makes estriol (the least potent, but a useful marker of fetal well-being since it rises roughly 1000-fold across pregnancy), and peripheral adipose tissue makes estrone via aromatization of androgens — this is the main source of estrogen after menopause and part of why postmenopausal obesity raises endometrial/breast cancer risk. Potency ranks estradiol > estrone > estriol.
- Androgens: the testis is the main source of testosterone and DHT; the adrenal cortex is the main source of DHEA and androstenedione. Potency ranks DHT > testosterone > androstenedione > DHEA. Testosterone itself drives growth of the penis/seminal vesicles, deepening of the voice, the male growth spurt, and libido, and (after peripheral aromatization to estrogen) closure of the epiphyseal plates; DHT specifically drives early differentiation of the penis/scrotum/prostate and, later in life, prostate growth and androgenic hair patterning/alopecia.
Autonomic Control of Male Sexual Response
- Erection is parasympathetic (pelvic splanchnic nerves, spinal levels S2–S4) — nitric oxide raises cGMP, relaxing smooth muscle and allowing arterial inflow; PDE-5 inhibitors work by preventing cGMP breakdown along this same pathway.
- Emission (movement of sperm/seminal fluid into the urethra) is sympathetic (hypogastric nerve, T11–L2).
- Expulsion (ejaculation itself) involves both visceral and somatic fibers via the pudendal nerve.
- A simple anchor: parasympathetic "points," sympathetic "squeezes" (emission), and the pudendal nerve "shoots" (expulsion) — the same S2–S4 roots that mediate erection also maintain the tone that keeps the penis from resting against the perineum.
Descent of the Gonads
- Both gonads originate high in the abdomen (near the future kidney level) and descend guided by the gubernaculum.
- Testis: descends fully through the inguinal canal into the scrotum — its accompanying peritoneal outpouching (processus vaginalis) normally obliterates, leaving the tunica vaginalis.
- Ovary: descends only into the pelvis; the gubernaculum remnant becomes the ovarian ligament (proximal) and round ligament of the uterus (distal, traverses the inguinal canal).
Perineal & Pelvic Floor Anatomy
- The perineum is conventionally split by an imaginary line between the two ischial tuberosities into two triangles: the urogenital triangle anteriorly (contains the external genitalia and urogenital diaphragm) and the anal triangle posteriorly (contains the anal canal and external anal sphincter).
- The perineal body is a fibromuscular node at the midpoint between the two triangles — several pelvic floor muscles converge here, which is why it is the structure deliberately incised (episiotomy) or torn during vaginal delivery.
- The urogenital diaphragm is the muscular sheet (bounded by superior and inferior fascial layers) that the urethra — and in females, the vagina — pierces on the way to the surface; it is the structural floor separating the deep and superficial perineal spaces.
- Superficial perineal fascia is continuous across regions under different names depending on location: Scarpa's fascia (anterior abdominal wall) continues as Colles' fascia (perineum) and, in the male, as Buck's/dartos-associated fascia of the penis — a single anatomic plane, three regional names.
- Erectile bodies: corpus cavernosum (paired, dorsal, primarily responsible for rigidity) and corpus spongiosum (single, ventral, surrounds the urethra and forms the glans — stays softer to keep the urethra patent during erection).
- Bulbospongiosus and ischiocavernosus muscles overlie the erectile bodies and assist erection/ejaculation and (in females) vaginal introitus constriction.
Scrotal Wall, Outside In
- Skin
- Dartos fascia/muscle (smooth muscle — responsible for scrotal wrinkling with cold/temperature regulation)
- External spermatic fascia (continuation of external oblique aponeurosis)
- Cremasteric fascia/muscle (continuation of internal oblique — this is what contracts in the cremasteric reflex)
- Internal spermatic fascia (continuation of transversalis fascia)
- Tunica vaginalis (the closed peritoneal remnant — parietal and visceral layers, the potential space where a hydrocele/hematocele collects)
Each layer corresponds to a specific abdominal wall layer that was carried down with testicular descent — useful for reasoning through surgical planes rather than memorizing a fixed list.
Digital Rectal Exam — What's Actually Being Assessed
- Anal sphincter tone: reflects intact S2–S4 innervation — a quick, bedside screen of the sacral reflex arc.
- Prostate (in males): palpable through the anterior rectal wall; size, symmetry, and nodularity are assessed (firm/nodular/asymmetric raises concern for carcinoma; smooth/symmetric enlargement favors BPH).
- Stool for occult blood, and detection of rectal masses, are the other core reasons for the exam.
- A pudendal nerve block for labor analgesia is landmarked off the ischial spine, where the pudendal nerve runs close to bone and is easiest to anesthetize.
- The interspinous (ischial spine-to-ischial spine) distance is the narrowest fixed diameter the fetal head must pass through during vaginal delivery, making it the classic measurement for assessing pelvic adequacy.
Genitourinary Trauma
- Most often blunt trauma (e.g., a motor vehicle collision).
- Renal injury: presents with flank bruising, flank pain, and hematuria, typically from a direct blow or a lower rib fracture.
- Bladder injury: a direct blow to a full bladder (classically a seatbelt) can rupture the dome — the weakest point — spilling urine into the peritoneal cavity, where it gets reabsorbed and raises BUN/creatinine. A pelvic fracture can instead perforate the anterior wall/neck of the bladder, leaking urine into the extraperitoneal (retropubic) space.
- Urethral injury occurs almost exclusively in males and presents with blood at the meatus, hematuria, and difficulty voiding — urethral catheterization should be avoided until the injury is characterized.
- Anterior urethral injury: a straddle injury tears the spongy urethra, causing a scrotal hematoma.
- Posterior urethral injury: a pelvic fracture disrupts the urethra at its weakest point (the bulbomembranous junction), leaking urine into the retropubic space and displacing the prostate upward ("high-riding" on exam).
🧬 Sexual Determination & Development
In-utero DES exposure (see the teratogen table below) causes Müllerian duct anomalies and, years later, a specific malignancy in the exposed daughter — vaginal clear cell adenocarcinoma, covered in Gynecologic Neoplasms → Vulvar & Vaginal Tumors.
Genetic vs. Gonadal vs. Phenotypic Sex
- Three separate layers of "sex" — genetic (karyotype), gonadal (histology of the gonad), and phenotypic (external appearance) — can be discordant in disease states.
- Gonads are bipotential through week 6; SRY protein (on the Y chromosome short arm) triggers testis-determining pathway starting week 7.
- No SRY → gonad defaults to ovary — female development is the constitutive/default pathway, not an actively induced one.
Female development is often mistaught as 'passive' — it isn't inert, it's the default outcome that proceeds unless SRY actively redirects it; every DSD in the anomalies section above is really a story of that redirect succeeding, failing, or going only partway.
Internal Duct Systems
- Two paired primordial duct systems coexist in the indifferent embryo:
- Paramesonephric (Müllerian) duct → fallopian tube, uterus, cervix, upper ~2/3 of the vagina
- Mesonephric (Wolffian) duct → epididymis, vas deferens, seminal vesicle, ejaculatory duct
- The lower ~1/3 of the vagina has a separate origin — it forms from the urogenital sinus (sinovaginal bulb) and fuses with the Müllerian-derived upper vagina; this is why a Müllerian anomaly can spare the lower vagina.
- The ovary itself is not a paramesonephric-duct derivative — its germ cells originate outside the duct system, in the yolk sac, and migrate into the genital ridge mesenchyme. The paramesonephric duct only builds the tube/uterus/cervix/upper vagina that connects to the ovary — it does not form the ovary. This is why conditions like Müllerian agenesis or androgen insensitivity can leave the uterus/upper vagina absent while gonadal tissue is normally present.
- Male pathway (testis present):
- Sertoli cells → Anti-Müllerian hormone (AMH) → paramesonephric duct regresses
- Leydig cells → testosterone → mesonephric duct is stabilized and virilized
- Female pathway (no testis): no AMH → paramesonephric duct persists and forms tract; no testosterone → mesonephric duct degenerates.
- The prostate is a separate story from both duct systems — it buds from the pelvic (urogenital sinus) endoderm under androgen stimulation, not from the mesonephric duct itself.
External Genitalia
- Driven by peripheral conversion of testosterone → dihydrotestosterone (DHT) via 5α-reductase in target tissue — a distinct hormone from what masculinizes the internal ducts.
- Genital tubercle → glans penis (male) / clitoris (female)
- Urogenital folds → penile shaft, spongy urethra (male, fuse in midline) / labia minora (female, stay open)
- Labioscrotal swellings → scrotum (male, fuse) / labia majora (female, stay separate)
- Urogenital sinus (the same DHT-sensitive tissue in males) → prostate gland and bulbourethral (Cowper) glands / — in females, the corresponding estrogen-driven tissue instead becomes the urethral and paraurethral (Skene) glands and the greater vestibular (Bartholin) glands.
- Testosterone masculinizes the internal Wolffian ducts.
- DHT masculinizes the external genitalia — this split explains 5α-reductase deficiency phenotypes below.
Gametogenesis Timing — a Frequently Tested Contrast
| Feature | Spermatogenesis | Oogenesis |
|---|---|---|
| Onset | Puberty, continuous | Prenatal life — arrested, then resumed episodically |
| Meiotic arrest point | No prolonged arrest | Arrested in prophase I from fetal life until ovulation; arrested again in metaphase II until fertilization |
| Product per parent cell | 4 equal haploid sperm | 1 haploid oocyte + polar bodies (unequal cytoplasmic division) |
| Supply | Effectively unlimited, renewed by stem spermatogonia | Fixed pool set before birth, depletes with age (and with X-linked/attrition disease) |
A distinction worth keeping straight: primary ciliary dyskinesia (Kartagener syndrome) impairs the sperm tail's own motility, causing infertility directly. Cystic fibrosis, by contrast, leaves sperm tail motility normal — infertility there comes from a structural problem (congenital bilateral absence of the vas deferens) rather than a motility defect.
Week-by-Week Milestones of Early Development
| Timepoint | What's happening |
|---|---|
| Week 1 | Fertilization in the ampulla → zygote → morula → blastocyst, which implants ("sticks") to the endometrium around day 6. hCG secretion from the syncytiotrophoblast begins around implantation. |
| Week 2 | The embryo becomes a bilaminar disc — two layers, epiblast and hypoblast. |
| Week 3 | Gastrulation converts the bilaminar disc into a trilaminar disc (epiblast cells migrate through the primitive streak to form all three germ layers: ectoderm, mesoderm, endoderm). The notochord forms from midline mesoderm and signals the overlying ectoderm to thicken into the neural plate, which folds into the neural tube. |
| Week 4 | The heart begins beating (already four-chambered) — cardiac activity is detectable by transvaginal ultrasound around this time. Upper and lower limb buds appear. |
| Week 8 | External genitalia become distinguishably male or female. This marks the end of the embryonic period — before this point, a teratogenic insult tends to be "all-or-none" (miscarriage or no effect); after it, teratogens instead disrupt growth and function of already-formed organs. |
Week 8 isn't just 'external genitalia form' — it's the developmental hinge for teratogen risk generally: before it, an insult tends to be all-or-none because organs haven't formed yet; after it, the same insult instead causes a specific structural or functional defect in an organ that already exists.
Twinning
- Dizygotic ("fraternal") twins come from two separately fertilized eggs — always two separate placentas and two separate amniotic sacs, regardless of timing.
- Monozygotic ("identical") twins come from a single fertilized egg that splits; how early the split happens determines how much the twins end up sharing:
- Split at days 0–4: separate chorion and amnion (dichorionic/diamniotic) — same as fraternal twins on imaging.
- Split at days 4–8 (most common timing): shared chorion, separate amnions (monochorionic/diamniotic).
- Split at days 8–12: shared chorion and shared amnion (monochorionic/monoamniotic) — higher-risk pregnancy.
- Split at day 13 or later: incomplete separation → conjoined twins.
- Twin-twin transfusion syndrome: occurs only in monochorionic pregnancies, where unbalanced vascular connections in the shared placenta shunt blood from one twin (donor — becomes volume-depleted, low amniotic fluid, "stuck" appearance) to the other (recipient — volume-overloaded, excess amniotic fluid).
Placenta & Amniotic Fluid
- The placenta has a fetal side and a maternal side. On the fetal side, the cytotrophoblast is the inner, cell-generating layer of the chorionic villi, while the syncytiotrophoblast is the outer, hormone-secreting layer (source of hCG) — it lacks class I MHC expression, which is thought to help it evade the maternal immune system. On the maternal side, the decidua basalis is endometrium-derived tissue containing the blood-filled lacunae where maternal and fetal circulations exchange gas and nutrients without directly mixing.
- Amniotic fluid is produced mainly by fetal urination (plus some fetal lung fluid) and cleared mainly by fetal swallowing.
- Polyhydramnios (too much fluid): seen when the fetus can't swallow normally — esophageal or duodenal atresia, anencephaly — or with maternal diabetes, fetal anemia, or a multiple gestation.
- Oligohydramnios (too little fluid): seen when the fetus can't produce/excrete urine normally — placental insufficiency, bilateral renal agenesis, posterior urethral valves. Severe, prolonged oligohydramnios can cause Potter sequence (limb and facial deformities, pulmonary hypoplasia, from physical compression without enough fluid cushioning).
- The umbilical cord normally contains two arteries (carry deoxygenated blood back to the placenta) and one vein (carries oxygenated blood to the fetus). A single umbilical artery ("two-vessel cord") is a soft marker for other congenital/chromosomal anomalies and warrants a closer anatomy survey.
Teratogen Exposures Worth Knowing Cold
| Exposure | Fetal effect |
|---|---|
| ACE inhibitors | Renal failure, oligohydramnios, skull ossification defects |
| Aminoglycosides | Ototoxicity (damage to the developing inner ear) |
| Antiepileptics (valproate, carbamazepine, phenytoin) | Neural tube defects, cardiac and craniofacial anomalies, digit/nail hypoplasia |
| Diethylstilbestrol (DES) | Vaginal clear cell adenocarcinoma and Müllerian anomalies in the exposed daughter, years later |
| Fluoroquinolones | Cartilage damage |
| Folate antagonists (trimethoprim, methotrexate) | Neural tube defects |
| Isotretinoin | Craniofacial, CNS, cardiac, and thymic defects — pregnancy must be excluded before starting therapy |
| Lithium | Ebstein anomaly (tricuspid valve malformation) |
| Methimazole | Aplasia cutis congenita (a patch of missing skin, typically on the scalp) |
| Tetracyclines | Tooth discoloration, inhibited bone growth |
| Thalidomide | Limb defects (phocomelia) |
| Warfarin | Bone/cartilage stippling, nasal and limb hypoplasia, CNS hemorrhage — switch to heparin in pregnancy, since it doesn't cross the placenta |
| Alcohol | Fetal alcohol syndrome — the leading preventable cause of intellectual disability, with microcephaly, smooth philtrum, thin upper lip, small palpebral fissures |
| Cocaine | Preterm birth, low birth weight, growth restriction — driven by cocaine-induced vasoconstriction |
| Tobacco smoking | Preterm birth, low birth weight, sudden infant death syndrome, ADHD — nicotine causes vasoconstriction and CO impairs fetal oxygen delivery |
| Iodine deficiency or excess | Congenital hypothyroidism |
| Maternal diabetes | Cardiac defects, neural tube defects, macrosomia, neonatal hypoglycemia (from fetal islet-cell hyperplasia); at the severe end, caudal regression syndrome |
| Maternal phenylketonuria (uncontrolled) | Growth restriction, microcephaly, intellectual disability, congenital heart defects |
| Methylmercury | Neurotoxicity — concentrates up the food chain in large predatory fish |
| X-rays | Microcephaly, intellectual disability — risk is minimized with lead shielding |
Grouping these by mechanism beats memorizing them individually: vasoconstrictors (cocaine, nicotine) cause growth restriction, folate-pathway disruptors (valproate, methotrexate, trimethoprim) cause neural tube defects, and enzyme/thyroid disruptors (warfarin, iodine, PKU) cause structurally distinct effects — sorting by mechanism also explains why isotretinoin and thalidomide, with no shared mechanism, don't fit either bucket.
Neonatal abstinence syndrome (most often from opioid exposure) is a distinct, non-teratogenic consequence of maternal substance use: the newborn experiences withdrawal after birth — poor feeding, irritability, high-pitched crying, tremors — rather than a structural birth defect; treatment is supportive, sometimes with a tapering opioid such as methadone or morphine.
- Agenesis — an organ never forms because the primordial tissue itself was never there.
- Aplasia/hypoplasia — the primordial tissue was present, but the organ failed to form (aplasia) or formed incompletely (hypoplasia).
- Malformation — an intrinsically abnormal developmental process during the embryonic period (e.g., cleft palate).
- Deformation — a later, extrinsic mechanical force distorts an otherwise normally-formed structure during the fetal period (e.g., clubfoot from oligohydramnios crowding).
- Disruption — secondary breakdown of a structure that had normal developmental potential (e.g., amniotic band syndrome).
- Sequence — a cascade of anomalies that all trace back to one single initiating problem (e.g., oligohydramnios → Potter sequence).
Umbilical & Vitelline Remnant Anomalies
- The urachus is the fetal connection between the bladder and the umbilicus (via the allantois); it should obliterate before birth into the median umbilical ligament. Incomplete closure produces a spectrum: total failure → urine draining from the umbilicus (patent urachus); partial failure → a fluid-filled urachal cyst that can become infected; slight failure → a small outpouching of the bladder (vesicourachal diverticulum).
- The vitelline (omphalomesenteric) duct connects the midgut to the yolk sac and normally closes around week 7. Its failure spectrum mirrors the urachus: total failure → meconium draining from the umbilicus; partial failure → a vitelline duct cyst (raises volvulus risk); slight failure → a Meckel diverticulum, a true outpouching of the ileum that's usually silent but can contain ectopic gastric or pancreatic tissue and bleed.
🧠 Behavioral Science: Development, Attachment & Sexuality
The abrupt postpartum mood shift below is driven by the same sharp estrogen/progesterone drop after placental delivery that unblocks prolactin and starts lactation, explained in Pregnancy, Placenta & Complications → Lactation — Why Milk Doesn't Come In Until After Delivery.
Developmental Frameworks Across the Lifespan
| Stage | Freud's psychosexual stage | Erikson's psychosocial crisis | Piaget's cognitive stage | Notable milestone |
|---|---|---|---|---|
| Infancy (0–1y) | Oral | Trust vs. mistrust | Sensorimotor | Social smile ~2mo, stranger anxiety ~6–9mo, object permanence by ~9–12mo |
| Toddler (1–3y) | Anal | Autonomy vs. shame/doubt | Preoperational (begins) | Parallel play, core gender identity solidifies ~2–3y |
| Preschool/school age | Phallic → latency | Initiative vs. guilt → industry vs. inferiority | Preoperational → concrete operations | Cooperative play, understanding of conservation by concrete operations |
| Adolescence | Genital | Identity vs. role confusion | Formal operations | Abstract reasoning, peer-group orientation, puberty |
| Early adulthood | — | Intimacy vs. isolation | — | Formation of committed relationships |
| Middle adulthood | — | Generativity vs. stagnation | — | Investment in the next generation/productive work |
| Late adulthood | — | Ego integrity vs. despair | — | Life review; women statistically outlive men |
Freud's framework proposes that psychic energy (libido) concentrates in a different bodily zone at each stage, and that unresolved conflict at any stage can leave a lasting personality imprint — a theoretical model rather than an empirically validated developmental sequence, unlike Piaget's stages.
Infant Reflexes & Gross Motor Milestones
Primitive reflexes (should disappear on schedule)
- Rooting & sucking: present at birth, fade by ~3–4 months
- Palmar grasp: present at birth, fades by ~4–6 months
- Babinski (upgoing toe): normal in infancy, should disappear once corticospinal myelination matures, typically within the first year
- Moro (startle): present at birth, fades by ~4–6 months
Persistence of primitive reflexes well past their expected window is a red flag for a central nervous system abnormality.
Gross motor milestones
- Rolls over: ~4–6 months
- Sits unsupported: ~6 months
- Walks independently: ~12 months
A useful rough anchor: most healthy infants roll, sit, and walk in that order across roughly the second half of the first year into the start of the second.
Postpartum Mood Changes
- "Baby blues": mild, self-limited low mood/tearfulness affecting roughly half of new mothers in the first couple weeks postpartum, driven by the abrupt hormonal shift plus sleep loss and role adjustment — resolves without treatment.
- Postpartum major depression: a smaller but clinically significant fraction of women develop true major depression after delivery, persisting beyond the transient blues and warranting active treatment — screening at postpartum visits is standard practice.
Early Attachment — Classic Developmental Experiments
- Harlow (rhesus monkeys): infants preferred a soft cloth surrogate over a wire surrogate that provided food — contact comfort, not just nutrition, drives attachment; prolonged isolation produced lasting social/behavioral deficits.
- Bowlby: formalized attachment theory — consistent, responsive caregiving in infancy predicts secure attachment and later relational functioning.
- Spitz: documented that infants deprived of adequate mothering/stimulation (e.g., in institutional settings) show developmental delay and increased susceptibility to illness.
- Mahler: described the infant's psychological journey from fusion with the mother toward an independent sense of self, moving through phases of increasing separation and individuation over the first few years.
- Anaclitic depression: a withdrawn, unresponsive state in an infant following prolonged separation from an established maternal attachment figure, roughly in the latter half of the first year.
Child Abuse — Recognition
- Risk factors cluster around caregiver stress and isolation: parental substance use, poverty, domestic conflict, single-parent households, unrelated male partner in the home.
- Physical abuse red flags: injuries inconsistent with the stated mechanism or the child's developmental stage, fractures in varying stages of healing, patterned bruising, delayed presentation for care.
- Sexual abuse red flags: genital/anal trauma, recurrent STIs or UTIs in a child, sexualized behavior inconsistent with age.
- Long-term sequelae: PTSD, dissociative symptoms, depression, disordered eating, personality pathology.
- Physicians are legally mandated reporters — reporting is required, not discretionary, once abuse is reasonably suspected.
Gender & Sexual Orientation — Definitions
- Gender identity: an individual's internal sense of their own gender.
- Gender expression/role: outward presentation of gender through behavior, dress, etc.
- Sexual orientation: the direction of romantic/sexual attraction — independent of gender identity.
- These three constructs are conceptually distinct and can vary independently of one another.
Sexual Response & Dysfunction
- Physiologic sexual response proceeds through excitement → plateau → orgasm → resolution.
- Erection depends on parasympathetic-mediated arteriolar dilation (nitric oxide/cGMP pathway) plus compression of venous outflow; ejaculation is a sympathetically mediated event.
- Distinguishing organic from psychogenic erectile dysfunction: preserved erections during sleep (nocturnal tumescence, associated with REM) point to a psychogenic cause, since the physical machinery is clearly intact.
- Common dysfunctions: premature ejaculation (most common male complaint), and difficulty with arousal/lubrication (most common female complaint); vaginismus (involuntary spasm of the outer vaginal musculature) is frequently linked to a history of sexual trauma.
Nocturnal tumescence is the single best bedside way to separate organic from psychogenic erectile dysfunction — preserved erections during REM sleep prove the vascular/neural machinery works, so a waking-only problem points to a psychological rather than physical cause.
Family Therapy — Core Concept
- Treats the family as an interdependent system rather than treating the symptomatic member in isolation — even if only one person carries a diagnosis, all members participate in sessions.
- Goals: identify maladaptive communication/behavior patterns that sustain the problem, and improve boundaries and problem-solving across the family unit.
Paraphilic Disorders
Defined by recurrent, intense sexual interest in atypical objects, situations, or nonconsenting others, of a degree that causes distress or risk of harm. The standard clinical categories:
| Term | Focus of interest |
|---|---|
| Exhibitionism | Exposing one's own genitals to an unsuspecting person |
| Voyeurism | Watching an unsuspecting person who is undressing, nude, or engaged in sexual activity |
| Fetishism | Nonliving objects (e.g., an article of clothing) |
| Frotteurism | Touching or rubbing against a nonconsenting person |
| Sexual masochism | Deriving pleasure from being humiliated or made to suffer |
| Sexual sadism | Deriving pleasure from inflicting humiliation or suffering on another |
| Pedophilic disorder | Prepubescent children — the most clinically and legally significant paraphilia; carries a mandatory reporting obligation if acted upon or disclosed as intended |
| Transvestic disorder | Cross-dressing for arousal, distinct from gender identity |